Key result
Multi-sequential CMR-predicted responders to cardiac resynchronization therapy had a higher clinical response rate at 6 months than predicted non-responders.
Why the study?
Does multi-sequential CMR predict clinical response and long-term prognosis following cardiac resynchronization therapy in patients with advanced heart failure?
Cohort (n=40)
Does multi-sequential CMR predict clinical response and long-term prognosis following cardiac resynchronization therapy in patients with advanced heart failure?
Answers are grounded in this paper and cite their sources.
Multi-sequential CMR combining dyssynchrony and scar imaging effectively predicts clinical response and long-term transplant-free survival in patients undergoing CRT.
AIMS: Cardiac resynchronization therapy (CRT) is advocated in advanced heart failure; however, patient selection remains challenging. We examined the utility of multi-sequential cardiac magnetic resonance imaging (CMR) in predicting outcome after CRT. METHODS AND RESULTS: We performed multi-sequential CMR on 40 subjects with cardiomyopathy and advanced heart failure, despite optimized medical therapy. All patients had been recommended for CRT according to accepted clinical guidelines. Patients were defined by CMR as likely responders if they had significant mechanical dyssynchrony (> or =65 ms delay between septal and posterolateral wall contraction on cine imaging), and no transmural scarring of the anteroseptal or posterolateral wall on delayed contrast-enhanced imaging. Clinical composite score was recorded at baseline and 6 months post-CRT. Long-term follow-up (transplant-free survival) was 497 +/- 55 days post-CRT. A clinical response was achieved in 19/26 (73%) of the CMR-predicted responders and 2/12 (17%) of the CMR-predicted non-responders (P < 0.01, chi(2)). The sensitivity of CMR for prediction of clinical response to CRT was 90%, with a specificity of 59%. Transplant-free survival post-CRT was achieved in 88% of the CMR-predicted responders and 58% of the CMR-predicted non-responders (P < 0.05, Kaplan-Meier survival analysis). CONCLUSION: Multi-sequential CMR identifies patients with severe cardiomyopathy who will respond to CRT with a favourable long-term prognosis.
No takes yet. Share an insight, caveat, or question.
Taylor et al. (2010) conducted a cohort in Cardiomyopathy and advanced heart failure (n=40). CMR-predicted responder status vs. CMR-predicted non-responder status was evaluated on Clinical response at 6 months post-CRT (p=< 0.01). Multi-sequential CMR-predicted responders to cardiac resynchronization therapy had a higher clinical response rate at 6 months than predicted non-responders.
Synapse has enriched 10 related papers. Consider them for comparative context: